Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025)
Corcept Therapeutics (CORT) posted Change in Taxes of $1.0 million for Q4 2025, up 167.57% sequentially from -$1.5 million in Q3 2025, and down 15.6% YoY from $1.2 million in Q4 2024.
Analysis
Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025) Analysis & Trends
Corcept Therapeutics has reported Change in Taxes for 5 years, with the latest figure at $1.0 million in Q4 2025.
- Quarterly Change in Taxes fell 15.6% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 71.09% YoY) and the FY2025 annual result came in at $1.1 million, down 71.09% from the prior year.
- Change in Taxes improved to $1.0 million in Q4 2025 per CORT's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Taxes peaked at $2.5 million in Q2 2022 and troughed at -$1.5 million in Q3 2025.
- A 5-year average of $738900.0 and a median of $579500.0 in 2021 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2022 and 2025: Change in Taxes jumped 56950.0% in 2022, then plunged 269.78% in 2025.
- Over 5 years, Change in Taxes stood at -$4000.0 in 2021, then surged by 56950.0% to $2.3 million in 2022, then tumbled by 107.17% to -$163000.0 in 2023, then jumped by 858.9% to $1.2 million in 2024, then decreased by 15.6% to $1.0 million in 2025.
- According to Business Quant data, Change in Taxes over the past three periods registered $1.0 million, -$1.5 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 910,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Sep 30, 2023 | 518,000.00 |
| Jun 30, 2023 | 553,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | -592,000.00 |
| Mar 31, 2021 | 597,000.00 |